BioNTech

A vaccine designed to help the body hunt down and destroy lung cancer cells has officially entered human trials, marking a major milestone in the fight against one of the deadliest diseases in the world. Researchers across seven countries have begun testing the treatment in patients, with hopes that it could dramatically improve survival rates and …

The syringe contained no poison to kill cancer cells, no radioactive particles to burn through tissue, no harsh chemicals to ravage a patient’s body. Instead, it held something far more revolutionary: a set of molecular instructions that would transform a 67-year-old scientist’s immune system into a personalized cancer-hunting army. Janusz Racz didn’t know it as …